Clinical Trial

Guided Imagery of the Gynecological Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated June 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized controlled trial is to evaluate the effectiveness of a guided imagery intervention in women receiving chemotherapy for gynecological cancers at Başkent University Ankara Hospital Outpatient Chemotherapy Unit. The main questions it aims to answer are: Does guided imagery improve psychological or physical outcomes during chemotherapy? How do outcomes differ between the intervention (guided imagery) and control (standard information) groups? Researchers will compare both groups to assess the effect of guided imagery across three repeated measurements. Participants will: * Be randomly assigned (1:1) to intervention or control groups via an online randomization tool. * Complete outcome assessments at three time points. * Be part of a sample of 158 women (minimum 76 per group), based on power analysis for repeated measures ANOVA (effect size f = 0.25, 95% power, 95% confidence). The study will follow the CONSORT-Outcomes 2022 guideline and be registered at ClinicalTrials.gov.
Trial Details
NCT Number NCT07408349
Lead Sponsor Baskent University
Conditions Gynecologic Cancer
Enrollment 46 participants
Start Date 2026-01-19
Primary Completion 2026-06-10 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13